Increased serological, cancer-associated protein biomarker levels at diagnosis of large bowel adenoma: Risk of subsequent primary malignancy?

CONCLUSION: Elevated blood-based, cancer-associated protein biomarker levels in subjects diagnosed with adenomas at large bowel endoscopy identifies subjects at increased risk of being diagnosed with subsequent primary malignancy. PMID: 30523734 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/30523734?dopt=Abstract

Source: Acta Oncologica - December 7, 2018 Category: Cancer & Oncology Authors: Piper TB, Jørgensen LN, Olsen J, Nielsen KT, Davis G, Johansen JS, Jarle Christensen I, Nielsen HJ Tags: Acta Oncol Source Type: research